|
|
||||||||
1 Molecular Biophysics Unit, Indian Institute of Science, Bangalore 560 012, India
2 National Centre for Biological Sciences, Tata Institute of Fundamental Research, GKVK Campus, Bangalore 560 065, India
3 Chemical Biology Unit, Jawaharlal Nehru Center for Advanced Scientific Research, Bangalore 560 004, India
Reprint requests to: Raghavan Varadarajan, Molecular Biophysics Unit, Indian Institute of Science, Bangalore 560012, India; e-mail:varadar{at} mbu.iisc.ernet.in; fax:91803600535 or 3600683.
(RECEIVED March 1, 2001; FINAL REVISION May 16, 2001; ACCEPTED May 17, 2001)
4 Present address: Life Sciences Addition Building, Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, California 947203200, USA. ![]()
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1101/ps.8101
| Abstract |
|---|
|
|
|---|
Keywords: Aggregation; intermediates; folding; MBP
Abbreviations: MBP, maltose-binding protein E. coli, Escherichia coli GdnHCl, guanidine hydrochloride CD, circular dichroism UV, ultraviolet BSA, bovine serum albumin RNase A, bovine pancreatic ribonuclease A
| Introduction |
|---|
|
|
|---|
Maltose binding protein (MBP) is a 370 amino acid, two-domain protein localized in the periplasm of E. coli. The folding of MBP has been studied, but most of the previous investigations were carried out using low protein concentrations, in the submicromolar range (Chun et al. 1993).We show here for the first time that MBP refolding is aggregation-prone, even at concentrations as low as a few micromolar. However, the large-scale aggregation and precipitation of refolding MBP is completely and spontaneously reversible, without any external aid. The redissolved protein is recovered in an active, folded form. We also examined the kinetics of MBP folding under nonaggregating conditions, using several spectroscopic probes, utilizing both rapid mixing stopped-flow and manual mixing techniques. We conducted these studies to identify intermediates that might be involved in the aggregation observed at higher protein concentrations. In addition, the effect of the cognate E. coli chaperone, SecB, on the aggregation of MBP was characterized.
| Results |
|---|
|
|
|---|
|
To determine the secondary structural content of the product(s) of the burst and fast phases, which are complete by 10 sec, we made manual measurements of ellipticity at 222 nm. Figure 1b
shows that the mean residue ellipticity at 222 nm increased from 10 sec (the earliest time point of measurement) to 100 sec in a single exponential process with an apparent rate constant of 0.058 ± .017 sec-1. Thus, within experimental error, the rate constants obtained for the slow phase using tryptophan (Trp) fluorescence and CD are identical. Extrapolation of the single exponential process to t = 0 indicates that only 30% of native-state ellipticity signal is recovered by 10 sec. Since stopped-flow CD measurements were not possible, it is not possible to determine what fraction of the native-state ellipticity signal is recovered in the burst phase of folding. The results in Figure 1b
do, however, indicate that the products of the burst and fast phases of folding represent only 30% of the secondary structure content of N. The kinetic parameters of all phases measurable by manual mixing at 25°C were found to be independent of protein concentration in the range 0.05 to 0.7 µM MBP (data not shown), suggesting that no concentration-dependent process such as aggregation occurs under these conditions at these low concentrations.
Because MBP is a large protein with several Pro residues, the folding pathway is expected to be complex and is likely to involve several intermediates and parallel pathways of folding. It should be emphasized that the objective of the present study was not to obtain a detailed and complete picture of MBP folding. Rather, it was to obtain some insight into the structural features of intermediate(s) that might be involved in the aggregation process that occurs when folding is carried out at higher protein concentrations (> 2 µM).
Spontaneously reversible precipitation during MBP refolding
When MBP unfolded in guanidine hydrochloride (GdnHCl) at high concentrations was diluted into refolding buffer, aggregation and large-scale precipitation perceptible to the naked eye occurred (Fig. 2ad
). Aggregation was also detected by optical scatter measurements in a photometer (Fig. 2e
). The inset in Figure 2e
shows that at a final MBP concentration of 28 µM, there was a lag of about 2 sec between denaturant dilution and the initiation of aggregation, and that aggregation was highly cooperative. Aggregation was maximal after about 60 sec and then gradually decreased. Refolding studies were also carried out at final MBP concentrations of 17, 34, and 51 µM. The lag phase was present at all four protein concentrations. This suggests that an intermediate on the folding pathway is likely to be responsible for the aggregation. It is also possible that the lag phase represents a slow nucleation event. The timescale of the lag phase indicates that even such a nucleation event is likely to involve intermediate(s) formed on the second timescale rather than the unfolded state. Refolding experiments at final MBP concentrations of 2, 4, and 8 µM were also carried out using manual mixing. Aggregation was monitored by following the intensity of scattered light at 320 nm as a function of time (Fig. 2f
). As expected for an aggregation process, the kinetics were concentration-dependent and the extent of aggregation increased with the increase in protein concentration.
|
Quantification of the partitioning of refolding MBP molecules between the soluble supernatant and the pellet, done using absorbance and fluorescence spectroscopy, indicates that roughly half the total protein is aggregated after a minute of refolding. This fraction declines gradually to zero at longer times of refolding (Table 1
). Thus, folded and active protein arises from both the soluble and aggregate phases. The results of the absorbance studies were in qualitative agreement with those of scattering experiments, suggesting that scattering could be used to follow the progress of aggregation and disaggregation. The time taken for the intensity of light scattering at 320 nm to fall to 50% of the maximal value (t50%) has been used as a convenient index to analyze refolding from the aggregated state.
|
|
Effect of chaperones on MBP aggregation and disaggregation
SecB is an E. coli chaperone (Kumamoto and Beckwith 1983) that binds MBP and a subset of proteins destined for export to the periplasm, and maintains them in an unfolded translocation competent state (Weiss et al. 1988). In our experiments, the addition of SecB to the refolding buffer led to a decrease in t50%, whereas another chaperone, GroEL (± GroES, ATP) had little or no effect on t50% (Fig. 4
). Other control proteins such as RNase A, lysozyme, and BSA had no effect (data not shown). The t50% value initially decreased with an increase in SecB concentration, but reached a plateau value of about 80 sec (Fig. 4b
). Thus, high concentrations of SecB diminish but cannot prevent MBP aggregation. SecB decreased t50% even when added after the onset of aggregation (Fig. 4a
, inset) and at times when there was no unfolded protein in the soluble supernatant. The absence of unfolded protein in the soluble supernatant at these times can be ascertained from the fact that the fluorescence in the supernatant does not change with the time of folding. SecB had no effect on the duration of the lag phase of aggregation (data not shown).
|
|
|
| Discussion |
|---|
|
|
|---|
In the next few seconds of folding, we observed minor changes in the burial of Trp residues. At the end of a few seconds of refolding, MBP has 30% of the native secondary structure, and there is substantial burial of Trp residues. We denote the collection of intermediates present after 2 seconds of refolding as Is. The major slow folding reaction of MBP occurs with an apparent half-life of about 15 sec (monitored by CD and Trp fluorescence). During this period, the protein acquires native secondary structure and tertiary structure. We denote the species formed at the end of this phase as N. The slow folding reaction is not due to proline isomerization (Ganesh et al. 1999). This was established by double-jump studies, which showed that the observed rate for the slow-phase amplitude buildup was about 100-fold faster than that expected for Pro isomerization (Ganesh et al. 1999).
N has native-like secondary structure and tryptophan fluorescence, and is an active form of MBP capable of binding maltose. Binding of maltose to MBP leads to a 15% decrease in Trp fluorescence. In refolding experiments carried out in the presence of maltose, we observed maltose binding only during the later stages of the slow phase, after about 3 min of refolding (data not shown). The inclusion of maltose had only marginal effects on the kinetics of the slow phase and did not affect the aggregation observed at high concentrations of MBP (data not shown).
The folding kinetics of MBP were studied here at low protein concentrations where not only is visible aggregation absent, but any events involving soluble aggregates must also be absent, because folding is concentration-independent. The folding kinetics were not studied in exhaustive detail because our goal was not to define the folding mechanism of MBP, but rather to determine which folding reaction occurs in the same time domain as the aggregation process. For this purpose, it is of course important to demonstrate that the kinetics of the folding reaction occurring along with the aggregation reaction are independent of protein concentration, as seen in Figure 3b
. Characterization of this folding reaction will allow determination of the structural features of the intermediate that are likely to be responsible for the aggregation process.
Folding and aggregation of MBP
The folding of MBP at micromolar concentrations involves the reversible formation of macroscopic aggregates. Since there is a lag phase in the formation of aggregates during folding, it is unlikely that aggregation is a direct result of a transfer of unfolded protein to refolding conditions. The formation of any aggregate, whether soluble or insoluble, would be expected to be strongly dependent on the concentration of protein. The lack of concentration dependence of the lag phase suggests that aggregation occurs directly from a folding intermediate that populates the folding pathway. It is also possible that the lag phase represents a nucleation event and the apparent lack of concentration dependence is simply because the size of the nucleus is small and the concentration range examined was insufficient. In either case, because of the timescales involved, aggregation is unlikely to be occurring directly from the unfolded state. Aggregates appear to be formed on the timescale of seconds and are completely dissociated after several minutes. However, the observed dissociation is likely to involve the net effect of both disaggregation and reaggregation events. It is difficult to characterize aggregation processes on the timescale of seconds. Hence, we attempted to first characterize the folding pathway of MBP at low concentrations where no aggregation occurs. On the timescale of a few seconds associated with aggregation, the intermediate(s) formed are collapsed molecules with about 30% of native secondary structure.
That we were able to observe only up to about half the amount of total protein in the aggregated state could be due to the following reasons. MBP has 21 proline residues, and during folding the proline residues will be in a mixture of cis and trans conformations. It is quite likely that only a subset of these conformational isomers are able to participate in the aggregation process. Secondly, the changes in scatter as a function of time illustrated in Figure 2
reflect the net effects of aggregation and disaggregation. It is not possible to deduce the rates for either aggregation or disaggregation from the data. The change in scatter with time shown in Figure 2f
is clearly and strongly concentration-dependent, as expected. Kinetic partitioning is likely to occur between the aggregation and the direct folding reaction to N, and would determine the fraction of molecules that fold through the aggregation pathway instead of folding directly.
Characterization of the disaggregation process
It is particularly interesting that when the aggregate is resolubilized, the resolubilized protein does not exhibit any change in fluorescence in a slow phase that is typically observed during MBP folding (Fig. 3a
, bottom curve). If the aggregate were to unfold to Is or earlier intermediates before refolding, a time-dependent change in Trp fluorescence that characterizes the Is
N transition would have been detected, as is the case for the protein in the soluble supernatant (Fig. 3a,
top curve). Thus, the aggregate appears competent to fold directly to N without first unfolding to U or even to Is. Hence the aggregated state appears to be an on-pathway aggregated intermediate.
Nature of the aggregation process
For reasons that are presently unclear, the temperature dependence of aggregation is surprisingly cooperative. One possible inference is that the aggregation process involves the participation of temperature-dependent hydrophobic forces, involving burial of nonpolar surfaces between protein molecules (Xie and Wetlaufer 1996). It is also possible that the observed effects are due to differential stabilization of an aggregation-prone intermediate with respect to the native state, as a function of temperature. Since MBP is a two-domain protein, one attractive possibility is that the precipitate consists of domain-swapped oligomers of the protein (Schlunegger et al. 1997). This would explain the observation that the precipitate is formed from a late intermediate, and that it can convert directly to the native state without unfolding.
Wild-type MBP can be expressed to levels as high as100 mg/L of E. coli culture. The protein can be produced either in the cytoplasm or in the periplasm. The in vivo levels of MBP in the periplasm can be as high as 1 mM (Dietzel et al. 1978). All of the protein is found in the soluble form. However, several MBP mutants form inclusion bodies in vivo and insoluble aggregates in vitro (Betton et al. 1998; Raffy et al. 1998). Studies of the folding pathways of such mutants and examination of those precipitates may yield further insights into the structural features responsible for reversible aggregation of the wild-type protein.
Role of cellular chaperones
Nascent polypeptide chains destined for translocation are expected to undergo competition between folding, misfolding events like aggregation, and the actual process of productive export. Folded or aggregated MBP is translocation-incompetent, and the cytosolic chaperone SecB is required for the efficient translocation of MBP (Collier et al. 1988). SecB is thought to function by maintaining a subset of precursor polypeptides in an export-competent form by preventing aggregation or folding, and delivering the precursors to the export apparatus located in the bacterial inner membrane (Hardy and Randall 1993). It has been shown that SecB can prevent the irreversible aggregation of two of its natural substrates, OmpA and PhoE (Lecker et al. 1990; Breukink et al. 1992). While we cannot rule out a role for SecB in prevention of MBP aggregation during refolding, the data also suggest that SecB promotes the rapid disaggregation of MBP without greatly enhancing the final yield of refolded MBP.
It was shown previously that the chaperone GroEL can interact with proOmpA and prePhoE (Lecker et al. 1989), two proteins destined for export across the bacterial membrane. The observation that SecB but not GroEL/GroES or other proteins specifically promotes MBP disaggregation is also of interest. The effect of GroEL on the refolding of MBP at low protein concentrations has been described (Sparrer et al. 1996) and was reproduced during the course of the present work (data not shown). However, our present findings indicate that the GroE chaperone system is incapable of preventing MBP aggregation at physiologically relevant concentrations.
Although the precursor form of MBP is the in vivo substrate for SecB in the E. coli cytoplasm, SecB binding sites are located primarily in the mature sequence of MBP (Gannon et al. 1989); therefore, the present findings using mature MBP are also relevant to the in vivo folding situation. It has been proposed (Betton and Hofnung 1996) that a newly exported protein in the bacterial periplasm undergoes kinetic competition among folding, proteolytic degradation, and aggregation. Mature MBP is located primarily in the bacterial periplasm, and thus it is important to determine whether there are any periplasmic chaperones which may suppress MBP aggregation (Wulfing and Pluckthun 1994; Betton and Hofnung 1996). Most known periplasmic chaperones are involved in either Pro isomerization or disulfide bond formation (Missiakas and Raina 1997). Neither of these processes are involved in the aggregation reported here. Initial experiments on the addition of bacterial periplasmic extracts to refolding MBP did not reveal any appreciable effect on the aggregation process (data not shown).
| General implications and conclusion |
|---|
|
|
|---|
A recent set of detailed investigations on the folding of interleukin 1ß (IL-1ß) (Finke et al. 2000a, b) has shed more light on the critical late stage at which commitment of a folding polypeptide to either the native state or insoluble aggregates occurs. A nucleation-dependent irreversible aggregate formation from the unstructured (unfolded) ensemble describes the off-pathway, nonproductive processes in the case of IL-1ß. The formation of self-solubilizing macroscopic precipitates and aggregation through folding intermediates in the case of MBP thus represent a different class of protein aggregation reaction. Further studies on the aggregation of several other proteins would prove vital in unraveling this complex process.
The classic studies by Anfinsen and colleagues (Anfinsen 1973) first showed that the sequence of a protein can contain sufficient information to specify its three-dimensional structure. It has been suggested that in addition, other molecules such as molecular chaperones (Morimoto et al. 1994) may be required for protein folding at high concentrations that occur in vivo. The present work shows that in the case of MBP, no additional information besides the amino acid sequence is required to attain the correct fold, and that correct and complete folding occurs even after large-scale protein aggregation and precipitation.
| Materials and methods |
|---|
|
|
|---|
Aggregation assay
Aggregation during MBP refolding was followed by monitoring the changes in light scatter intensity at 320 nm in a JASCO 7850 spectrophotometer, a JASCO FP 777 spectrofluorimeter, a SPEX Fluorolog fluorimeter, or a BioLogic SFM4 stopped-flow instrument with a deadtime of 1.4 msec. Typically, 200 µM of unfolded MBP in 3 M GdnHCl was diluted to the desired final concentration in refolding buffer, and aggregation was monitored as a function of time. At 24°C, aggregation was observed for final concentrations of MBP greater than 2 µM and at final GdnHCl concentrations in the range of 0.050.4 M. Manual mixing aggregation assays were performed at different temperatures and in the presence of several additives.
Spectroscopic methods
Far-UV and near-UV CD spectra were acquired in a JASCO 500A spectropolarimeter using a 1mm (far-UV) or 5 mm (near-UV and refolding kinetics at 222 nm) quartz cuvette. MBP concentrations of 0.7 µM, 2 µM and 20 µM were used for the refolding (monitored at 222 nm), far-UV, and near-UV experiments, respectively. The deadtime for the manual mixing CD refolding experiment was 4 sec. Steady-state fluorescence emission spectra and refolding kinetics traces (excitation at 280 nm and emission at 341 nm) after manual mixing were recorded in a JASCO FP777 spectrofluorimeter. All experiments were conducted in 10 mM HEPES buffer containing 150 mM NaCl (pH 7.3) (refolding buffer). For equilibrium near-UV CD measurements, 71 µL of 280 µM unfolded MBP (in 3 M GdnHCl) was mixed with 930 µL refolding buffer (final MBP concentration during refolding was 20 µM). Precipitation visible to the naked eye occurred but faded away completely with time, and CD spectra were recorded after equilibration as described (Ganesh et al. 1997).
Kinetics experiments and data analyses
The kinetics of MBP refolding under nonaggregating conditions were monitored at a protein concentration of about 0.5 µM MBP in refolding buffer containing 0.15 M GdnHCl, at 24°C. Rapid mixing experiments were performed in a Biologic SFM 4 stopped-flow instrument. The excitation wavelength was set to 280 nm, and correspondingly a 320 nm Oriel cut-off filter was used to monitor Trp fluorescence. Changes in signal intensity as a function of time in all kinetics experiments were fit to either of the equations a
+
ai*exp(-ki*t) or a0+
ai*[1-exp(-ki*t)], where ai represents the amplitude change associated with the process occurring with an observed rate constant of ki. a0 is the amplitude change occurring within the burst phase and a
represents the amplitude achieved at equilibrium. All curve-fitting procedures were performed as described (Agashe et al. 1995).
Refolding kinetics from the aggregated state
Experiments were also performed to follow the refolding from the precipitate. Twenty µM MBP was first refolded in 0.1 mL of 0.35 M GdnHCl for 20 sec at 30°C. To separate the precipitate from soluble protein, the sample was then centrifuged at 12,000 x g for 10 sec. All of the supernatant (0.1 mL) was removed and diluted to 1 mL in refolding buffer. The folding kinetics of MBP in the diluted supernatant were monitored by Trp fluorescence at 340 nm. The pellet which contained the aggregated MBP was immediately redissolved in 1 mL of fresh refolding buffer, briefly recentrifuged for 10 sec and then transferred to a 1-mL fluorescence cuvette. The increase in Trp fluorescence intensity of the material in the redissolved pellet was monitored at 340 nm as a function of time.
Mass balance and activity of recovered MBP
In a refolding experiment carried out at a final MBP concentration of 20 µM, the sample was centrifuged after 20 sec of refolding. The supernatant was removed from the pellet and the latter was separately resolubilized with fresh refolding buffer. The binding affinities of maltose to MBP present in the soluble supernatant and to MBP obtained from the resolubilized pellet were both determined, as described (Ganesh et al. 1997). In a separate set of experiments carried out at a final concentration of 5 µM MBP, the sample was centrifuged after variable times of refolding. At each time of folding, the amount of protein in both soluble supernatant and resolubilized pellet were quantitated by UV absorbance at 280 nm and by fluorescence spectroscopy (Ganesh et al. 1997). The results are summarized in Table 1
.
Electron microscopy and Congo red dye binding
Amyloid fibrils were prepared by heating 12 mM insulin in HCl (pH 2) at 75°C for 4 h. The excess acid was removed, and the precipitate was washed and then resuspended in fresh distilled water. MBP precipitate was prepared in situ by refolding 10 µM protein in 0.1 M GdnHCl (described above) directly on carbon-coated copper grids. Both the samples were negatively stained with 2% (w/v) aqueous uranyl acetate solution and examined in a JOEL 100 CX II electron microscope operated at 80 kV. For the Congo red binding experiments, the insulin precipitates were stained for
30 min with freshly prepared 50 µM aqueous Congo red dye solution. MBP precipitation was carried out on a clean glass slide for 20 sec, and then the dye was mixed with the precipitate. The stained samples were covered with a clean glass cover slip and viewed under both normal and polarized light in an optical microscope (magnification 250400-fold).
| Acknowledgments |
|---|
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| References |
|---|
|
|
|---|
Anfinsen, C.B. 1973. Principles that govern the folding of protein chains. Science 181: 223230.
Betton, J. and Hofnung, M. 1996. Folding of a mutant maltose-binding protein of Escherichia coli which forms inclusion bodies. J. Biol. Chem. 271: 80468052.
Betton, J.M., Sassoon, N., Hofnung, M., and Laurent, M. 1998. Degradation versus aggregation of misfolded maltose-binding protein in the periplasm of Escherichia coli. J. Biol. Chem. 273: 88978902.
Brems, D.N. 1990. Deciphering the second half of the genetic code. In Protein folding (eds. L.M. Gierasch and J. King), pp. 129135. American Association For The Advancement of Science.
Breukink, E., Kusters, R., and De Kruijff, B. 1992. In vitro studies on the folding characteristics of the Escherichia coli precursor protein prePhoE. Evidence that SecB prevents the precursor from aggregating by forming a functional complex [published erratum appears in Eur. J. Biochem. 1993 Feb 1;211 (3):909]. Eur. J. Biochem. 208: 419425.[Medline]
Carrell, R.W. and Lomas, D.A. 1997. Conformational disease. Lancet 350: 134138.[CrossRef][Medline]
Chun, S.Y., Strobel, S., Bassford, Jr., P., and Randall, L.L. 1993. Folding of maltose-binding protein. Evidence for the identity of the rate-determining step in vivo and in vitro. J. Biol. Chem. 268: 2085520862.
Collier, D.N., Bankaitis, V.A., Weiss, J.B., and Bassford, Jr., P.J. 1988. The antifolding activity of SecB promotes the export of the E. coli maltose-binding protein. Cell 53: 273283.[CrossRef][Medline]
di Guan, C., Li, P., Riggs, P.D., and Inouye, H. 1988. Vectors that facilitate the expression and purification of foreign peptides in Escherichia coli by fusion to maltose-binding protein. Gene 67: 2130.[CrossRef][Medline]
Dietzel, I., Kolb, V., and Boos, W. 1978. Pole cap formation in Escherichia coli following induction of the maltose-binding protein. Arch. Microbiol. 118: 207218.[CrossRef][Medline]
Finke, J.M., Gross, L.A., Ho, H.M., Sept, D., Zimm, B.H., and Jennings, P.A. 2000a. Commitment to folded and aggregated states occurs late in interleukin- 1ß folding. Biochemistry 39: 1563315642.[CrossRef][Medline]
Finke, J.M., Roy, M., Zimm, B.H., and Jennings, P.A. 2000b. Aggregation events occur prior to stable intermediate formation during refolding of interleukin 1ß. Biochemistry 39: 575583.[CrossRef][Medline]
Ganesh, C., Banerjee, A., Shah, A., and Varadarajan, R. 1999. Disordered N-terminal residues affect the folding thermodynamics and kinetics of maltose binding protein. FEBS Lett. 454: 307311.[CrossRef][Medline]
Ganesh, C., Shah, A.N., Swaminathan, C.P., Surolia, A., and Varadarajan, R. 1997. Thermodynamic characterization of the reversible, two-state unfolding of maltose binding protein, a large two-domain protein. Biochemistry 36: 50205028.[CrossRef][Medline]
Gannon, P.M., Li, P., and Kumamoto, C.A. 1989. The mature portion of Escherichia coli maltose-binding protein (MBP) determines the dependence of MBP on SecB for export. J. Bacteriol. 171: 813818.
Hardy, S.J. and Randall, L.L. 1993. Recognition of ligands by SecB, a molecular chaperone involved in bacterial protein export. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 339: 343352; discussion 352354.[Medline]
Harrison, P.M., Chan, H.S., Prusiner, S.B., and Cohen, F.E. 1999. Thermodynamics of model prions and its implications for the problem of prion protein folding. J. Mol. Biol. 286: 593606.[CrossRef][Medline]
Kapust, R.B. and Waugh, D.S. 1999. Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci. 8: 16681674.[Abstract]
Kedar, I., Ravid, M., and Sohar, E. 1976. In vitro synthesis of "amyloid" fibrils from insulin, calcitonin and parathormone. Isr. J. Med. Sci. 12: 11371140.[Medline]
Kiefhaber, T., Rudolph, R., Kohler, H.H., and Buchner, J. 1991. Protein aggregation in vitro and in vivo: a quantitative model of the kinetic competition between folding and aggregation. Biotechnology (NY). 9: 825829.[CrossRef][Medline]
King, J., Haase-Pettingell, C., Robinson, A.S., Speed, M., and Mitraki, A. 1996. Thermolabile folding intermediates: Inclusion body precursors and chaperonin substrates. FASEB J. 10: 5766.[Abstract]
Kumamoto, C.A. and Beckwith, J. 1983. Mutations in a new gene, secB, cause defective protein localization in Escherichia coli. J. Bacteriol. 154: 253260.
Lecker, S., Lill, R., Ziegelhoffer, T., Georgopoulos, C., Bassford, Jr., P.J., Kumamoto, C.A., and Wickner, W. 1989. Three pure chaperone proteins of Escherichia coliSecB, trigger factor and GroELform soluble complexes with precursor proteins in vitro. EMBO J. 8: 27032709.[Medline]
Lecker, S.H., Driessen, A.J., and Wickner, W. 1990. ProOmpA contains secondary and tertiary structure prior to translocation and is shielded from aggregation by association with SecB protein. EMBO J. 9: 23092314.[Medline]
Missiakas, D. and Raina, S. 1997. Protein folding in the bacterial periplasm. J. Bacteriol. 179: 24652471.
Morimoto, R.I., Tissieres, A., and Georgepoulos, C. 1994. The biology of heat shock proteins and molecular chaperones. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Panse, V.G., Udgaonkar, J.B., and Varadarajan, R. 1998. SecB binds only to a late native-like intermediate in the folding pathway of barstar and not to the unfolded state. Biochemistry 37: 1447714483.[CrossRef][Medline]
Pecorari, F., Minard, P., Desmadril, M., and Yon, J.M. 1996. Occurrence of transient multimeric species during the refolding of a monomeric protein. J. Biol. Chem. 271: 52705276.
Raffy, S., Sassoon, N., Hofnung, M., and Betton, J.M. 1998. Tertiary structure-dependence of misfolding substitutions in loops of the maltose-binding protein. Protein Sci. 7: 21362142.[Abstract]
Raman, B., Ramakrishna, T., and Rao, C.M. 1996. Refolding of denatured and denatured/reduced lysozyme at high concentrations. J. Biol. Chem. 271: 1706717072.
Schlunegger, M.P., Bennet, M.J., and Eisenberg, D. 1997. Oligomer formation by 3D domain swapping: A model for protein assembly and misassembly. Adv. Prot. Chem. 50: 61122.[Medline]
Silow, M. and Oliveberg, M. 1997. Transient aggregates in protein folding are easily mistaken for folding intermediates. Proc. Natl. Acad. Sci. 94: 60846086.
Silow, M., Tan, Y.J., Fersht, A.R., and Oliveberg, M. 1999. Formation of short-lived protein aggregates directly from the coil in two-state folding. Biochemistry 38: 1300613012.[CrossRef][Medline]
Sparrer, H., Lilie, H., and Buchner, J. 1996. Dynamics of the GroEL-protein complex: Effects of nucleotides and folding mutants. J. Mol. Biol. 258: 7487.[CrossRef][Medline]
Weiss, J.B., Ray, P.H., and Bassford, Jr., P.J. 1988. Purified secB protein of Escherichia coli retards folding and promotes membrane translocation of the maltose-binding protein in vitro. Proc. Natl. Acad. Sci. 85: 89788982.
Wulfing, C. and Pluckthun, A. 1994. Correctly folded T-cell receptor fragments in the periplasm of Escherichia coli. Influence of folding catalysts. J. Mol. Biol. 242: 655669.[CrossRef][Medline]
Xie, Y. and Wetlaufer, D.B. 1996. Control of aggregation in protein refolding: The temperature-leap tactic. Protein Sci. 5: 517523.[Abstract]
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. W. Kim, K. S. Han, K.-S. Ryu, B. H. Kim, K.-H. Kim, S. I. Choi, and B. L. Seong N-terminal domains of native multidomain proteins have the potential to assist de novo folding of their downstream domains in vivo by acting as solubility enhancers Protein Sci., April 1, 2007; 16(4): 635 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Winter, P. Klappa, R. B. Freedman, H. Lilie, and R. Rudolph Catalytic Activity and Chaperone Function of Human Protein-disulfide Isomerase Are Required for the Efficient Refolding of Proinsulin J. Biol. Chem., January 4, 2002; 277(1): 310 - 317. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK |